Announce Date | 09/04/2025 |
EPS Normalized Actual | $0.41 (Beat by $0.0487) |
EPS GAAP Actual | $0.41 (Beat by $0.0487) |
Revenue Actual | $1.21172B |
Revenue Surprise | Beat by $1211.72M |
Announce Date | 07/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.415 |
EPS GAAP Estimate | $0.415 |
Revenue Estimate | $1.181218333B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jul 2028 | 2.22 | 22.02 | 2.1327 | 2.34339 | 1 |
Jul 2027 | 1.9 | 25.73 | 1.83199 | 1.97011 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.42 | -0.015 | 1.21172B | 6.97% | -55.69M |
FQ1 2025 (Jan 2025) | 0.4 | 0.01 | 1.16332B | 12.31% | 21.45M |
FQ4 2024 (Oct 2024) | 0.38 | 0.38 | 1.14683B | 11.02% | 1146.83M |
FQ3 2024 (Jul 2024) | 0.34 | 0.34 | 1.069B | 6.68% | 1069M |
FQ2 2024 (Apr 2024) | 0.4 | 0.4 | 1.12726B | 9.35% | 1127.26M |
FQ1 2024 (Jan 2024) | 0.33 | 0.33 | 1.02015B | 6.22% | 1020.15M |
FQ4 2023 (Oct 2023) | 0.35 | 0.35 | 1.02042B | 12.45% | 1020.42M |
FQ3 2023 (Jul 2023) | 0.36 | 0.36 | 0.997591B | 11.45% | 997.59M |
FQ4 Announce Date
07/30/2025 (Pre-Market)
Consensus EPS Estimates
0.415
Consensus Revenue Estimates
1.181218333B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 0.45 | -- | 0.43819 | 0.46302 | 3 |
FQ2 2027 (Apr 2027) | 0.52 | -- | 0.50636 | 0.53504 | 4 |
FQ1 2027 (Jan 2027) | 0.46 | -- | 0.44793 | 0.47331 | 5 |
FQ4 2026 (Oct 2026) | 0.41 | -- | 0.39924 | 0.42186 | 5 |
FQ3 2026 (Jul 2026) | 0.44 | -- | 0.42658 | 0.4587 | 2 |
FQ2 2026 (Apr 2026) | 0.47333 | 11.27 | 0.45524 | 0.49005 | 1 |
FQ1 2026 (Jan 2026) | 0.418 | 4.31 | 0.40662 | 0.42966 | 2 |
FQ4 2025 (Oct 2025) | 0.43 | 11.63 | 0.41689 | 0.44828 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 1.28B | -- | 1.26B | 1.31B | 4 |
FQ2 2027 (Apr 2027) | 1.37B | -- | 1.35B | 1.41B | 5 |
FQ1 2027 (Jan 2027) | 1.3B | -- | 1.27B | 1.33B | 6 |
FQ4 2026 (Oct 2026) | 1.24B | -- | 1.22B | 1.27B | 6 |
FQ3 2026 (Jul 2026) | 1.28B | -- | 1.25B | 1.32B | 3 |
FQ2 2026 (Apr 2026) | 1.37B | 11.24 | 1.33B | 1.4B | 2 |
FQ1 2026 (Jan 2026) | 1.24B | 6.47 | 1.22B | 1.27B | 3 |
FQ4 2025 (Oct 2025) | 1.24B | 7.6 | 1.21B | 1.28B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.435 | 0.42 | -0.015 | -3.57% |
FQ1 2025 (Jan 2025) | 0.39 | 0.4 | 0.01 | 2.5% |
FQ4 2024 (Oct 2024) | 0.38 | 0.38 | 100% | |
FQ3 2024 (Jul 2024) | 0.34 | 0.34 | 100% | |
FQ2 2024 (Apr 2024) | 0.4 | 0.4 | 100% | |
FQ1 2024 (Jan 2024) | 0.33 | 0.33 | 100% | |
FQ4 2023 (Oct 2023) | 0.35 | 0.35 | 100% | |
FQ3 2023 (Jul 2023) | 0.36 | 0.36 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $1.27B | $1.21B | $-55.69M | -4.6% |
FQ1 2025 (Jan 2025) | $1.14B | $1.16B | $21.45M | 1.84% |
FQ4 2024 (Oct 2024) | $0B | $1.15B | $1146.83M | 100% |
FQ3 2024 (Jul 2024) | $0B | $1.07B | $1069M | 100% |
FQ2 2024 (Apr 2024) | $0B | $1.13B | $1127.26M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.02B | $1020.15M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.02B | $1020.42M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1B | $997.59M | 100% |